プログラム
全体
| 7月11日（水） | 19:00- | カクテルパーティー |
|---|---|---|
| 7月12日（木） | 9:00-12:00 | 国際会議 |
| 12:00-13:30 | 昼食 | |
| 13:30-17:10 | 国際シンポジウム | |
| 18:00- | 懇親会 | |
| 7月13日（金） | 9:00-12:00 | 国際会議 |
| 閉会式 |
国際会議
| Date | Time | Session Title | Chairpersons | Agenda |
|---|---|---|---|---|
| July 12th | 9:00-10:20 | 1. Epidemiology and Clinical Diagnosis | Isao Hamaguchi Lloyd Einsiedel Graham Taylor |
1. Current status of infection and transmission 2. Clinical epidemiology 3. Risk evaluation |
| 10:20-10:40 | Coffee Break | |||
| 10:40-12:00 | 2. Virology | Renaud Mahieux Masao Matsuoka Anne Van den Broeke |
1. Function of viral gennes 2. Viral immunology 3. Proviral insertion |
|
| July 13th | 9:00-10:20 | 3. Pathogenesis of associated diseases | Charles Bangham Steven Jacobson Toshiki Watanabe |
1. Genomic abonormalities 2. Epigenetic abnormalities 3. Gene expression |
| 10:20-10:40 | Coffee Break | |||
| 10:40-12:00 | 4. Prevention and Therapy | Yoshi Yamano Kunihiro Tsukasaki Olivier Hermine |
1. Drug discovery and Preclinical studies 2. Clinical trials 3. Guidelines for HAM/TSP and ATL |
国際シンポジウム
| Speaker | Title of speech | |||
|---|---|---|---|---|
| July 12th | 13:30-13:55 | 1 | Antoine Gessain | Epidemiology and Origin of HTLV-1 and Related Viruses Infection |
| 13:55-14:20 | 2 | Lloyd Einsiedel | THE HUMAN T LYMPHOTROPIC VIRUS TYPE 1 SUBTYPE C: A MAJOR CAUSE OF MORBIDITY AND MORTALITY FOR INDIGENOUS AUSTRALIANS | |
| 14:20- 14:45 | 3 | Veffa Franchini | Do biological differences exist between HTLV-1A and HTLV-1C? | |
| 14:45-15:10 | 4 | Eduardo Gotuzzo | What we have learned from Peru Cohort | |
| 15:10-15:30 | Coffee Break | |||
| 15:30:-15:55 | 5 | Renaud Mahieux | Primate model for studying HTLV-1 infection | |
| 15:55:-16:20 | 6 | Charles Bangham | HTLV-1: pathogenesis and regulation of latency | |
| 16:20-16:45 | 7 | Yoshihisa Yamano | Treatment of HAM/TSP | |
| 16:45-17:10 | 8 | Makoto Yamagishi | Development of an epigenetic drug against ATL | |
| 18:00 | Banquet | |||
